Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total weighted-average anti-dilutive common share equivalents (in shares) | 100,798 | 35,025 |
| Unvested Restricted Shares | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Unvested restricted shares outstanding (in shares) | 100,789 | 34,837 |
| Unvested Restricted Shares | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total weighted-average anti-dilutive common share equivalents (in shares) | 100,798 | 35,025 |